Study provides insights into how HCMV infection causes birth defects

Fresh insights into how a common virus replicates could pave the way for new therapies to stop its spread.

Scientists have discovered a key molecule linked to Human Cytomegalovirus (HCMV) infection, which is harmless for healthy people but can cause miscarriage and birth defects during pregnancy.

Tests on infected cells found that blocking the molecule with a chemical inhibitor stops the virus from multiplying.

The molecule - called VCP - is a component of the infected cell rather than a substance produced by the virus itself.

Researchers at the University of Edinburgh's Roslin Institute found the virus is dependent on VCP to replicate its genetic material and multiply.

Chemicals that block the activity of VCP are 10 times more powerful at stopping the virus than existing medications that target HCMV directly, the study found.

By targeting the affected cells instead of the virus, the approach could also cut the chances of the virus becoming resistant to the therapy, researchers say.

Drugs that target VCP are already being developed as potential therapies for cancer. Studies to check whether the drugs are safe for use will be needed before they could be tested as a therapy for the virus.

HCMV is extremely common. It infects at least 30 percent of the population in the developed world and up to 100 percent of people in developing countries.

It can be life-threatening for people with a weakened immune system, such as transplant recipients and people infected with HIV.

Infection during pregnancy can lead to hearing loss and intellectual disabilities in unborn babies.

The study is published in the journal PLOS Pathogens.

Dr Finn Grey, a Senior Research Fellow at the University of Edinburgh's Roslin Institute, said: "Human Cytomegalovirus infection is an important human disease. By gaining a better understanding of how the virus works, we can develop improved antiviral drugs. While more work is required, this study shows the potential of such approaches."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses